Search

Search any products, services and so on here.

About 16311 result(s)

Global Sodium Oxybate Oral Solution Market Research Report 2024

  • Sep 18, 24
  • ID: 553607
  • Pages: 72
  • Figures: 71
  • Views: 0
  • From $2,900

Sodium oxybate oral solution is a prescription medication used to treat narcolepsy, a condition characterized by excessive daytime sleepiness and cataplexy (sudden loss of muscle tone). The global Sodium Oxybate Oral Solution market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. North American market fo...


Global Sodium Oxybate Oral Medications Market Research Report 2024

  • Sep 18, 24
  • ID: 553606
  • Pages: 67
  • Figures: 71
  • Views: 0
  • From $2,900

Sodium oxybate oral medications are specialized treatments used to manage narcolepsy.Administered in liquid form, sodium oxybate is typically taken before bedtime in divided doses to address both nighttime and daytime symptoms. The global Sodium Oxybate Oral Medications market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the foreca...


Global Lurasidone Hydrochloride Generics Market Research Report 2024

  • Sep 18, 24
  • ID: 553605
  • Pages: 105
  • Figures: 100
  • Views: 0
  • From $2,900

Lurasidone hydrochloride generics are alternative versions of the brand-name medication lurasidone, used primarily to treat schizophrenia and bipolar disorder. The global Lurasidone Hydrochloride Generics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. North American market for Lurasidone Hydrochl...


Global Sitagliptin Phosphate/metformin Hydrochloride Tablets Market Research Report 2024

  • Sep 18, 24
  • ID: 553604
  • Pages: 95
  • Figures: 97
  • Views: 0
  • From $2,900

Sitagliptin phosphate/metformin hydrochloride tablets are a combination medication used to treat type 2 diabetes. This dual-action drug combines sitagliptin phosphate, a DPP-4 inhibitor that enhances insulin secretion and reduces glucose production in the liver, with metformin hydrochloride, a biguanide that decreases hepatic glucose output and improves insulin sensitivity. The global Sitagliptin...


Global Teriflunomide API Market Research Report 2024

  • Sep 18, 24
  • ID: 553603
  • Pages: 117
  • Figures: 115
  • Views: 0
  • From $2,900

Teriflunomide API (Active Pharmaceutical Ingredient) refers to the pure, active compound used in the formulation of medications for treating multiple sclerosis. It is the key ingredient in drugs designed to reduce the frequency of relapses and slow the progression of the disease by modulating the immune system. The global Teriflunomide API market was valued at US$ million in 2023 and is anticipate...


Global Teriflunomide Tablets Market Research Report 2024

  • Sep 18, 24
  • ID: 553602
  • Pages: 101
  • Figures: 107
  • Views: 0
  • From $2,900

Teriflunomide tablets are a pyrimidine synthesis inhibitor indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease,and active secondary progressive disease, in adults. The global Teriflunomide Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of...


Global Fingolimod Hydrochloride Capsules Market Research Report 2024

  • Sep 18, 24
  • ID: 553601
  • Pages: 91
  • Figures: 93
  • Views: 0
  • From $2,900

Fingolimod hydrochloride capsules are a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older The global Fingolimod Hydrochloride Capsules market was valued at US$ million in 2023 and is...


Global Dimethyl Fumarate Delayed-release Capsules Market Research Report 2024

  • Sep 18, 24
  • ID: 553600
  • Pages: 90
  • Figures: 93
  • Views: 0
  • From $2,900

Dimethyl fumarate delayed-release capsules are a prescription medication used primarily to treat multiple sclerosis. The capsules contain dimethyl fumarate, which has anti-inflammatory and neuroprotective properties. The global Dimethyl Fumarate Delayed-release Capsules market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forec...


Global Oral Medications for Multiple Sclerosis Market Research Report 2024

  • Sep 18, 24
  • ID: 553598
  • Pages: 113
  • Figures: 114
  • Views: 0
  • From $2,900

Oral medications for Multiple Sclerosis (MS) are drugs that work by targeting the immune system to reduce inflammation, prevent relapses, or slow the progression of the disease,including dimethyl fumarate, teriflunomide, fingolimod, Ozanimod and so on. The global Oral Medications for Multiple Sclerosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnes...


Global Linagliptin and Metformin Hydrochloride Tablets Market Research Report 2024

  • Sep 18, 24
  • ID: 553595
  • Pages: 100
  • Figures: 101
  • Views: 0
  • From $2,900

Linagliptin and Metformin Hydrochloride Tablets are a prescription medication used to manage type 2 diabetes. This combination medication includes two active ingredients: linagliptin and metformin hydrochloride. The global Linagliptin and Metformin Hydrochloride Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the foreca...


Our team would be happy to assist you with your queries.

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232